BOTULINUM TOXIN FOR PAIN SYNDROMES

Abstract

The purpose of this scientific review was to analyze and summarize the most relevant and new published scientific data on the effectiveness of antinociceptive action of botulinum toxin type A (BTA). The publications were searched for in the Medline, Pub med, Cochrane Library databases. As a result, high-level evidence was selected (RCT, national clinical guidelines, international clinical guidelines, meta-analyzes, systematic reviews). The article is devoted to the problem of pain syndromes in various neurological disorders, features and efficacy of antinociceptive action of botulinum toxin type A (BTA). Data on the efficacy of onаbotulotoxin (Botox®) in the treatment of pain syndromes are presented in accordance with the recorded indications. Also, based on the analysis, it was shown that BTA therapy is a valuable alternative to traditional therapy for many conditions accompanied by pain syndromes.

Keywords

• pain
• botulinum toxin
• onbotulotoxin
• botox®
• chronic migraine
• spasticity
• focal dystonia